Midlife Blood Pressure, Amyloid-β, and Risk for Alzheimer Disease One More Reason to Treat Hypertension

被引：7
|
作者：
Elias, Merrill F. [1 ,2 ]
Davey, Adam [3 ]
机构：
[1] Univ Maine, Dept Psychol, Orono, ME 04469 USA
[2] Univ Maine, Grad Sch Biomed Sci, Orono, ME 04469 USA
[3] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA
来源：
HYPERTENSION | 2012年 / 59卷 / 04期
关键词：
PULSE-WAVE VELOCITY;
D O I：
10.1161/HYPERTENSIONAHA.111.189464
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [41] Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease
    Kivipelto, M
    Helkala, EL
    Laakso, MP
    Hänninen, T
    Hallikainen, M
    Alhainen, K
    Iivonen, S
    Mannermaa, A
    Tuomilehto, J
    Nissinen, A
    Soininen, H
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (03) : 149 - 155
  • [42] Intravascular β-amyloid infusion increases blood pressure:: implications for a vasoactive role of β-amyloid in the pathogenesis of Alzheimer's disease
    Arendash, GW
    Su, GC
    Crawford, FC
    Bjugstad, KB
    Mullan, M
    NEUROSCIENCE LETTERS, 1999, 268 (01) : 17 - 20
  • [43] Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer’s disease via impacting on peripheral innate immune cells
    Mingchao Shi
    Fengna Chu
    Feiqi Zhu
    Jie Zhu
    Journal of Neuroinflammation, 21
  • [44] Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer's disease via impacting on peripheral innate immune cells
    Shi, Mingchao
    Chu, Fengna
    Zhu, Feiqi
    Zhu, Jie
    JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
  • [45] Is P-glycoprotein Involved in Amyloid-β Elimination Across the Blood-Brain Barrier in Alzheimer's Disease?
    Ohtsuki, S.
    Ito, S.
    Terasaki, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (04) : 443 - 445
  • [46] Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition
    Estrada, Lisbell D.
    Chamorro, David
    Jose Yanez, Maria
    Gonzalez, Marcelo
    Leal, Nancy
    von Bernhardi, Rommy
    Dulcey, Andres E.
    Marugan, Juan
    Ferrer, Marc
    Soto, Claudio
    Zanlungo, Silvana
    Inestrosa, Nibaldo C.
    Alvarez, Alejandra R.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (03) : 1193 - 1205
  • [47] Amyloid-β40 E22K fibril in familial Alzheimer's disease is more thermostable and susceptible to seeding
    Lee, Ming-Che
    Liao, Yi-Hung
    Chen, Shih-Hui
    Chen, Yun-Ru
    IUBMB LIFE, 2022, 74 (08) : 739 - 747
  • [48] Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss
    Salazar, Santiago, V
    Cox, Timothy O.
    Lee, Suho
    Brody, A. Harrison
    Chyung, Annabel S.
    Haas, Laura T.
    Strittmatter, Stephen M.
    JOURNAL OF NEUROSCIENCE, 2019, 39 (04): : 758 - 772
  • [49] WHICH MEASUREMENT OF BLOOD PRESSURE IS MORE ASSOCIATED WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITHOUT HYPERTENSION: CENTRAL BLOOD PRESSURE OR PERIPHERAL BLOOD PRESSURE?
    Kim, G.
    Moon, D.
    Lee, S. N.
    Kim, J. H.
    Moon, K. W.
    Yoo, K. D.
    Kim, C. M.
    JOURNAL OF HYPERTENSION, 2016, 34 : E214 - E214
  • [50] Non-Dipping Blood Pressure or Nocturnal Hypertension: Does One Matter More?
    Tang, Amber
    Yang, Eugene
    Ebinger, Joseph E.
    CURRENT HYPERTENSION REPORTS, 2024, 26 (01) : 21 - 30
12345